Skip to main content
Log in

Association of Maternal Serum Ischemia Modified Albumin (IMA) with Placental Histopathological Changes and Fetomaternal Outcome: A Prospective Case Control Study in Normotensive and Pre-eclamptic Women

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Introduction

Ischemia and oxidative stress leads to generation of hydroxyl free radicals and modification of ‘N-terminus’ of human serum albumin. This modified albumin molecule, known as Ischemia Modified Albumin (IMA), is elevated in early stages of ischemia. It has recently been approved by US Food and Drug Administration (US FDA) for its clinical use, as early marker of myocardial ischemia in cardiology. IMA is a novel marker of ischemia and is elevated in other clinical conditions associated with ischemia like pulmonary embolism, uncontrolled type II diabetes mellitus, acute decompensated heart failure, preeclampsia, recurrent pregnancy losses and IUGR. Role of IMA in birth asphyxia in perinatology is of current interest and needs further research.

Methodology

A prospective case control study was conducted in a tertiary center in North India for one year. Total 80 pregnant women between 34 and 40 weeks were recruited and allocated in two groups. Case group comprised of 40 pre-eclamptic pregnant women and control group comprised of 40 normotensive pregnant women. Comparison and association of maternal serum IMA levels with fetomaternal outcome and number and types of placental histopathological changes was done in two groups.

Results

In preeclampsia group mean serum IMA (115.23 ± 49.51) was significantly higher as compared to the normotensive group (79.21 ± 14.35). The optimum cut off value of IMA to detect a case was 94.5 IU/ml (sensitivity 65%, specificity 87.5%, PPV 83.9%, NPV 71.4% and diagnostic accuracy of 76.3). Pre-eclamptic women, had significantly higher incidence of PTVD, lower fetal birth weight and placental histopathological changes as compared to normotensive group. 83.8% of the women with raised IMA levels were pre-eclamptic. Raised IMA levels were significantly associated with higher incidence of PTVD, birth weight ≤ 2 kg and hypoxic histopathological lesions of chorangiosis, intervillous fibrin and hyalinization.

Conclusion

Determination of maternal serum IMA levels early in pregnancy can predict preeclampsia and avoid future severe preeclampsia related complications. It might be useful to optimize both maternal and fetal/neonatal outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Oran I, Oran B. Ischemia-modified albumin as a marker of acute coronary syndrome: the case for revising the concept of “N-Terminal Modification to Fatty Acid Occupation” of albumin. Dis Markers. 2017;2017:5692583.

    Article  Google Scholar 

  2. Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009;24(4):333–41.

    Article  CAS  Google Scholar 

  3. Anwaruddin S, Januzzi JL Jr, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol. 2005;123(1):140–5.

    Article  CAS  Google Scholar 

  4. Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046.

    Article  Google Scholar 

  5. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med. 2008;26(8):874–8.

    Article  Google Scholar 

  6. Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand. 2009;88(4):479–82.

    Article  CAS  Google Scholar 

  7. Raijmakers MT, Roes EM, Poston L, Steegers EA, Peters WH. The transient increase of oxidative stress during normal pregnancy is higher and persists after delivery in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2008;138:3944.

    Article  Google Scholar 

  8. Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod. 2008;23:803–6.

    Article  CAS  Google Scholar 

  9. Üstün Y, Engin-Üstün Y, Öztürk Ö, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med. 2011;24(3):418–21.

    Article  Google Scholar 

  10. Stanek J. Hypoxic patterns of placental injury: a review. Arch Pathol Lab Med. 2013;137(5):706–20.

    Article  Google Scholar 

  11. Yarcı Gursoy A, Caglar GS, Demirtas S. Ischemia modified albumin in perinatology. Eur J Obstet Gynecol Reprod Biol. 2017;210:182–8.

    Article  Google Scholar 

  12. Roy N, Sahana Y. Serum ischemia modified albumin as a potent biochemical marker in pre-eclampsia patients attending a tertiary care hospital in central India. Int J Clin Biochem Res. 2019;6(2):209–12.

    Article  Google Scholar 

  13. Van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy. 2008;27(2):159–67.

    Article  Google Scholar 

  14. Karaşin SS, Çift T. The role of ischemia-modified albumin as a biomarker in preeclampsia. Rev Bras Ginecol Obstet. 2020;42(3):133–9.

    Article  Google Scholar 

  15. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27:939–58.

    Article  CAS  Google Scholar 

  16. Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol. 1998;179:1359–75.

    Article  CAS  Google Scholar 

  17. Jena I, Nayak SR, Behera S, et al. Evaluation of ischemia-modified albumin, oxidative stress, and antioxidant status in acute ischemic stroke patients. J Nat Sci Biol Med. 2017;8(1):110–3.

    Article  Google Scholar 

  18. Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(5):1496.

    Article  Google Scholar 

  19. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–7.

    Article  Google Scholar 

  20. Grill S, Rusterholz C, Zanetti-Dällenbach R, et al. Potential markers of preeclampsia—a review. Reprod Biol Endocrinol. 2009;7:70.

    Article  Google Scholar 

  21. Bahinipati J, Mohapatra PC, Pradhan T. Role of maternal serum ischemia modified albumin as a biochemical marker in preeclampsia. Biomed Res. 2014;25(2):153–6.

    Google Scholar 

  22. Vyakaranam S, Bhongir AV, Patlolla D, Chintapally R. Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study. Int J Reprod Contracept Obstet Gynecol. 2015;4(3):611–6.

    Article  Google Scholar 

  23. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83. https://doi.org/10.1016/j.preghy.2012.01.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Vafaei H, Karimi Z, Akbarzadeh-Jahromi M, Asadian F. Association of placental chorangiosis with pregnancy complication and prenatal outcome: a case-control study. BMC Pregnancy Childbirth. 2021;21(1):99.

    Article  Google Scholar 

  25. Loukeris K, Sela R, Baergen RN. Syncytial knots as a reflection of placental maturity: reference values for 20 to 40 weeks’ gestational age. Pediatr Dev Pathol. 2010;13(4):305–9. https://doi.org/10.2350/09-08-0692-OA.1 (PMID: 20017638).

    Article  PubMed  Google Scholar 

  26. Majumdar S, Dasgupta H, Bhattacharya A. A study on placenta in normal and hypertensive pregnancies. J Anat Soc India. 2005;54:34–8.

    Google Scholar 

  27. Kambale T, Iqbal B, Ramraje S, Swaimul K, Salve S. Placental morphology and fetal implications in pregnancies complicated by pregnancy-induced hypertension. Med J DY Patil Univ. 2016;9:341–7.

    Article  Google Scholar 

  28. Salmani D, Purushothaman S, Somashekara SC, et al. Study of structural changes in placenta in pregnancy-induced hypertension. J Nat Sci Biol Med. 2014;5(2):352–5. https://doi.org/10.4103/0976-9668.136182.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Rossi A, Romanello I. Ischemia-modified albumin in pregnancy. Am J Obstet Gynecol. 2017;27:159.

    Google Scholar 

  30. Kiseli M, Gürsoy AY, Akincioglu E, Çağlar GS, Çandar T, Demirtaş S. The association between ischemia modified albumin and placental histopathology in uncomplicated term deliveries. Placenta. 2015;36(9):1056–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monica Agrawal.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

Ethical approval from institutional Ethical Committee KGMU, Lucknow, was taken.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dr. S. P. Jaiswar is Professor at Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, India; Dr. Shikha Verma is Senior Resident at Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, India; Dr. Monica Agrawal is Associate Professor at Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, India; Dr. Sujata Deo is Professor at Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, India; Dr. Madhumati Goel is Professor at Department of Pathology, King George Medical University, Lucknow, India; Dr. Abbas Ali Mahdi is Professor & Head at Department of Biochemistry, King George Medical University, Lucknow, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jaiswar, S.P., Verma, S., Agrawal, M. et al. Association of Maternal Serum Ischemia Modified Albumin (IMA) with Placental Histopathological Changes and Fetomaternal Outcome: A Prospective Case Control Study in Normotensive and Pre-eclamptic Women. J Obstet Gynecol India 72 (Suppl 1), 166–173 (2022). https://doi.org/10.1007/s13224-021-01614-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-021-01614-7

Keywords

Navigation